| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/09/1994 | EP0420914B1 Cosmetic and skin treatment compositions |
| 03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004676A1 Stress protein epitopes |
| 03/03/1994 | WO1994004565A2 Ipnv vaccine |
| 03/03/1994 | WO1994004564A1 T cell epitopes of ryegrass pollen allergen |
| 03/03/1994 | WO1994004561A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994004171A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994001451A3 Method for modification of recombinant polypeptides |
| 03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
| 03/03/1994 | WO1993010747A3 Technetium-99m labeled peptides for imaging |
| 03/03/1994 | CA2142990A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | CA2142306A1 Cationic peptides and method for production |
| 03/02/1994 | EP0584360A1 Wf11243 substance |
| 03/02/1994 | EP0584290A1 Endothelin antagonists |
| 03/02/1994 | EP0584256A1 Method for detecting an localizing tissues having neurokinine 1 receptors |
| 03/02/1994 | EP0584247A1 Compositons for the treatment of chronic fatigue syndrome |
| 03/02/1994 | EP0584244A1 Peptide inhibitors of inflammation |
| 03/02/1994 | EP0584136A1 Determination of motifs of peptides on mhc molecules |
| 03/02/1994 | EP0584082A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 03/02/1994 | EP0470980B1 Synthetic peptides for an hiv-1 vaccine |
| 03/02/1994 | CN1083075A Linear peptides |
| 03/01/1994 | CA2101599A1 Tri- and tetracyclic compounds |
| 03/01/1994 | CA1327329C Recombinant diphtheria toxin fragments |
| 02/23/1994 | EP0583894A2 Method of immobilizing and orienting molecules by use of metal chelating moieties to facilitate atomic force microscopy of proteins and molecular scale manipulation |
| 02/23/1994 | EP0583338A1 Method for synthesizing peptides, novel amino acid derivatives used therein, and methods for preparing same. |
| 02/22/1994 | US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides |
| 02/22/1994 | CA1327162C Method for prophylactically treating an individual for an autoimmune disease |
| 02/17/1994 | WO1994003813A1 Immunoassay for detecting collagen or collagen fragments |
| 02/17/1994 | WO1994003494A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | WO1994003490A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 02/17/1994 | WO1994003488A1 Novel peptide |
| 02/17/1994 | WO1994003479A1 Thrombin receptor antagonists |
| 02/17/1994 | WO1994003468A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
| 02/17/1994 | WO1994003201A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | WO1994003059A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 02/17/1994 | WO1993025577A3 Active component of parathyroid hypertensive factor |
| 02/17/1994 | WO1993018054A3 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 02/17/1994 | CA2141588A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | CA2141581A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
| 02/17/1994 | CA2141447A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | CA2139592A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/17/1994 | CA2119873A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation |
| 02/16/1994 | EP0583074A2 Angiotensin converting enzyme inhibitor and method for preparing same |
| 02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
| 02/16/1994 | EP0387285B1 Emulsifiers |
| 02/16/1994 | CN1082053A Synthetic polypeptides |
| 02/16/1994 | CN1082052A Preparation and application of memory enhancing peptide (MEP) |
| 02/15/1994 | US5286730 Administering rapamycins for skin disorders |
| 02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
| 02/09/1994 | EP0582243A2 HCV peptide antigens and a method of testing for the hepatitis C virus (HCV) |
| 02/08/1994 | US5284826 Treating transplant rejection and autoimmune diseases |
| 02/08/1994 | CA2103533A1 Hcv peptide antigens and method of determining hcv |
| 02/03/1994 | WO1994002589A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
| 02/03/1994 | WO1994002507A2 Methods for detecting pre-clinical iddm |
| 02/03/1994 | WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression |
| 02/03/1994 | WO1994002225A1 Sorbent families |
| 02/03/1994 | WO1994002163A1 Neuromedin b receptor antagonists |
| 02/03/1994 | WO1994002162A1 Peptide medicaments for treating disease |
| 02/03/1994 | WO1994002018A1 Peptides capable of controlling acrosome reaction |
| 02/03/1994 | DE4225038A1 Herstellung und Verwendung von Antikörpern gegen Kollagen Preparation and use of antibodies against collagen |
| 02/03/1994 | CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression |
| 02/03/1994 | CA2140257A1 Sorbent families |
| 02/03/1994 | CA2140033A1 Peptide medicaments for treating disease |
| 02/03/1994 | CA2120014A1 Peptides capable of controlling acrosome reaction |
| 02/03/1994 | CA2118588A1 Neuromedin b receptor antagonists |
| 02/02/1994 | EP0580694A1 Production of phosphopeptides from casein |
| 02/02/1994 | EP0246307B1 Cys codon-modified dna |
| 02/01/1994 | US5283321 Polypeptide compound which binds to glyco-conjugates and to artificial pertussis toxin antigen |
| 01/31/1994 | CA2101614A1 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 01/30/1994 | CA2101476A1 Method of immobilizing and orienting molecules by use of metal chelating moieties to facilitate atomic force microscopy of proteins and molecular scale manipulation |
| 01/29/1994 | CA2074790A1 Methods for detecting pre-clinical iddm |
| 01/26/1994 | EP0579823A1 New hexapeptidic derivatives, preparation, method and application as medicaments of said new derivatives |
| 01/26/1994 | EP0579785A1 Substituted benzhydrylamines as handles for solid phase peptide synthesis. |
| 01/26/1994 | EP0579763A1 Novel peptide compositions and uses therefor |
| 01/26/1994 | EP0579758A1 Parathyroid hormone receptor and dna encoding same |
| 01/26/1994 | EP0579661A1 Branched peptides in assays for antibodies |
| 01/26/1994 | EP0579640A1 Glial mitogenic factors, their preparation and use |
| 01/26/1994 | EP0579611A1 Peptides |
| 01/26/1994 | EP0579602A1 Vasopressin and vasotocin derivates |
| 01/26/1994 | EP0423301B1 Synthetic peptides of the conjugate of ubiquitine and histone h2a |
| 01/26/1994 | EP0417165B1 Polypeptide compounds having growth hormone releasing activity |
| 01/26/1994 | CN1081205A N-acetylglucosaminyltransferase V protein and gene |
| 01/25/1994 | CA1326459C Diagnostic peptides of human papilloma virus |
| 01/24/1994 | CA2100926A1 Culture system for anchorage dependent cells |
| 01/20/1994 | WO1994001458A1 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them |
| 01/20/1994 | WO1994001451A2 Method for modification of recombinant polypeptides |
| 01/20/1994 | CA2140002A1 A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof |
| 01/20/1994 | CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/19/1994 | EP0578728A1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa |
| 01/19/1994 | CN1080959A Recombinant stimulating factor of the neu receptor |
| 01/19/1994 | CN1080926A Cyclic peptide antifungal agents and process for preparation thereof |
| 01/19/1994 | CN1080916A Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 01/18/1994 | US5280106 Pentapeptide; collagenase inhibitor |
| 01/18/1994 | US5279812 Radiolabeled anticoagulant peptides |
| 01/12/1994 | EP0578521A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them |
| 01/12/1994 | EP0578293A1 E-coli P-fimbrine as immunogenic carrier system against GnRH |
| 01/12/1994 | EP0578083A2 Cyclic adhesion inhibitors |
| 01/12/1994 | EP0577775A1 Anti-thrombotic peptides and pseudopeptides |